Keywords: s-p, 3rd-qtr, net, income, surges, drug, major
S-P's 3rd-qtr 2007 net income surges 149%
Article | 29 October 2007
US drug major Schering-Plough's third-quarter 2007 net income totaled $713.0 million, or $0.45 per common share, versus $287.0 million, or $0.19 per share, in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
